Pentwater Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Pentwater Capital Management’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,500,000	Closed	-$36.5M	–	176
2023 Q1	$36.5M	Buy	+2,500,000	New	+$35.3M	0.35%	49

Pentwater Capital Management's AMYT Position: Q2 2023 in Review

Pentwater Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 2,500,000 shares — an estimated $36.5M sold.

Pentwater Capital Management first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $36.5M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Pentwater Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Pentwater Capital Management sold 2,500,000 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $36.5M.
Pentwater Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2023 and held it in 1 quarter.
Pentwater Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $36.5M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Pentwater Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.